0
13

In This Issue
  |  
The American Journal of Psychiatry

March 01, 2006, Vol. 163, No. 3
Get Alert | RSS  
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

In This Issue
In This Issue
Editorials
Targeting Schizophrenia Research to Patient Outcomes
WILLIAM T. CARPENTER, Jr., M.D.
Understanding the Glass Ceiling for Functional Outcome in Schizophrenia
CAMERON S. CARTER, M.D.
Stimulant Medications: How to Minimize Their Reinforcing Effects?
NORA D. VOLKOW, M.D.
Are We Still Talking to Our Patients With Schizophrenia?
SAMUEL J. KEITH, M.D.
Reviews and Overviews
Cognitive Behavior Therapy for Schizophrenia
Douglas Turkington, M.D.; David Kingdon, M.D.; Peter J. Weiden, M.D.
Article
PET Study Examining Pharmacokinetics, Detection and Likeability, and Dopamine Transporter Receptor Occupancy of Short- and Long-Acting Oral Methylphenidate
Thomas J. Spencer, M.D.; Joseph Biederman, M.D.; Patrick E. Ciccone, M.D.; Bertha K. Madras, Ph.D.; Darin D. Dougherty, M.D.; Ali A. Bonab, Ph.D.; Elijahu Livni, Ph.D.; Dolly A. Parasrampuria, Ph.D.; Alan J. Fischman, M.D., Ph.D.
A PET Study Evaluating Dopamine D2 Receptor Occupancy for Long-Acting Injectable Risperidone
Gary Remington, M.D., Ph.D., FRCPC; David Mamo, M.D., M.Sc., FRCPC; Alain Labelle, M.D., FRCPC; Jeffrey Reiss, M.D., FRCPC; Chekkera Shammi, M.B.B.S., FRCPC; Erik Mannaert, Ph.D.; Steve Mann, B.A.; Shitij Kapur, M.D., Ph.D., FRCPC
A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone Maintenance Treatment in Children and Adolescents With Disruptive Behavior Disorders
Magali Reyes, M.D., Ph.D.; Jan Buitelaar, M.D.; Paz Toren, M.D.; Ilse Augustyns, Ph.D.; Marielle Eerdekens, M.D.
Barriers to Employment for People With Schizophrenia
Robert Rosenheck, M.D.; Douglas Leslie, Ph.D.; Richard Keefe, Ph.D.; Joseph McEvoy, M.D.; Marvin Swartz, M.D.; Diana Perkins, M.D., M.P.H.; Scott Stroup, M.D., M.P.H.; John K. Hsiao, M.D.; Jeffrey Lieberman, M.D.; CATIE Study Investigators Group
Determinants of Real-World Functional Performance in Schizophrenia Subjects: Correlations With Cognition, Functional Capacity, and Symptoms
Christopher R. Bowie, Ph.D.; Abraham Reichenberg, Ph.D.; Thomas L. Patterson, Ph.D.; Robert K. Heaton, Ph.D.; Philip D. Harvey, Ph.D.
The Schizophrenia Cognition Rating Scale: An Interview-Based Assessment and Its Relationship to Cognition, Real-World Functioning, and Functional Capacity
Richard S.E. Keefe, Ph.D.; Margaret Poe, M.A.; Trina M. Walker, R.N.; Joseph W. Kang, M.A.; Philip D. Harvey, Ph.D.
Prognostic Variables at Intake and Long-Term Level of Function in Schizophrenia
Steven J. Siegel, M.D., Ph.D.; Farzin Irani, M.S.; Colleen M. Brensinger, M.S.; Christian G. Kohler, M.D.; Warren B. Bilker, Ph.D.; J. Daniel Ragland, Ph.D.; Stephen J. Kanes, M.D., Ph.D.; Ruben C. Gur, Ph.D.; Raquel E. Gur, M.D., Ph.D.
Impairment in the Specificity of Emotion Processing in Schizophrenia
Frank Schneider, M.D., Ph.D.; Ruben C. Gur, Ph.D.; Kathrin Koch, M.A.; Volker Backes, M.A.; Katrin Amunts, M.D.; N. Jon Shah, Ph.D.; Warren Bilker, Ph.D.; Raquel E. Gur, M.D., Ph.D.; Ute Habel, Ph.D.
Social Perception as a Mediator of the Influence of Early Visual Processing on Functional Status in Schizophrenia
Mark J. Sergi, Ph.D.; Yuri Rassovsky, Ph.D.; Keith H. Nuechterlein, Ph.D.; Michael F. Green, Ph.D.
Functional and Structural Deficits in Brain Regions Subserving Face Perception in Schizophrenia
Toshiaki Onitsuka, M.D., Ph.D.; Margaret A. Niznikiewicz, Ph.D.; Kevin M. Spencer, Ph.D.; Melissa Frumin, M.D.; Noriomi Kuroki, M.D.; Lisa C. Lucia, B.S.; Martha E. Shenton, Ph.D.; Robert W. McCarley, M.D.
Abnormalities of Thalamic Activation and Cognition in Schizophrenia
Jessica Andrews, B.S.; Lei Wang, Ph.D.; John G. Csernansky, M.D.; Mokhtar H. Gado, M.D.; Deanna M. Barch, Ph.D.
Sex Differences in Language Dysfunction in Schizophrenia
Deborah J. Walder, Ph.D.; Larry J. Seidman, Ph.D.; Nicole Cullen, B.A.; Jessica Su, M.A.; Ming T. Tsuang, M.D., Ph.D., D.Sci.; Jill M. Goldstein, Ph.D.
Regional Brain Morphometry in Patients With Schizophrenia or Bipolar Disorder and Their Unaffected Relatives
Colm McDonald, M.R.C.Psych., Ph.D.; Nicolette Marshall, M.Sc.; Pak C. Sham, M.R.C.Psych., Ph.D.; Edward T. Bullmore, M.R.C.Psych., Ph.D.; Katja Schulze, M.Sc.; Ben Chapple, B.A.; Elvira Bramon, M.D.; Francesca Filbey, Ph.D.; Seema Quraishi, Ph.D.; Muriel Walshe, B.A.; Robin M. Murray, F.R.C.Psych., D.Sc.
Negative Signs and Symptoms Secondary to Antipsychotics: A Double-Blind, Randomized Trial of a Single Dose of Placebo, Haloperidol, and Risperidone in Healthy Volunteers
Juan Francisco Artaloytia, M.D.; Celso Arango, M.D.; Adrienne Lahti, M.D.; Javier Sanz, M.D.; Ana Pascual, M.D.; Pedro Cubero, M.D.; David Prieto, M.Sc.; Tomás Palomo, M.D.
Sildenafil in the Treatment of Antipsychotic-Induced Erectile Dysfunction: A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose, Two-Way Crossover Trial
Rajesh Gopalakrishnan, M.D., D.P.M.; K.S. Jacob, M.D., Ph.D., M.R.C.Psych.; Anju Kuruvilla, M.D.; B. Vasantharaj, M.Sc.; Jacob K. John, M.D., F.R.C.Psych.
Assessment of Therapeutic Misconception in Older Schizophrenia Patients With a Brief Instrument
Laura B. Dunn, M.D.; Barton W. Palmer, Ph.D.; Monique Keehan, B.A.; Dilip V. Jeste, M.D.; Paul S. Appelbaum, M.D.
Association Between the CCR5 32-bp Deletion Allele and Late Onset of Schizophrenia
Henrik Berg Rasmussen; Sally Timm; August G. Wang; Karen Søeby; Henrik Lublin; Mogens Fenger; Ralf Hemmingsen; Thomas Werge
Improving the Accuracy of the Diagnosis of Schizophrenia by Means of Virtual Reality
Anna Sorkin, B.Sc.; Daphna Weinshall, Ph.D.; Ilan Modai, M.D., M.H.A.; Avi Peled, M.D.
Association of Schizophrenia and Autoimmune Diseases: Linkage of Danish National Registers
William W. Eaton, Ph.D.; Majella Byrne, Ph.D.; Henrik Ewald, Dr.Med.Sc.; Ole Mors, Ph.D.; Chuan-Yu Chen, Ph.D.; Esben Agerbo, M.S.; Preben Bo Mortensen, M.D., Dr.Med.Sc.
Clinical Case Conference
The Development of the Self in the Era of the Internet and Role-Playing Fantasy Games
Sara E. Allison, M.D.; Lisa von Wahlde, L.M.S.W.; Tamra Shockley, M.S.; Glen O. Gabbard, M.D.
Brief Report
DRD2 Promoter Region Variation as a Predictor of Sustained Response to Antipsychotic Medication in First-Episode Schizophrenia Patients
Todd Lencz, Ph.D.; Delbert G. Robinson, M.D.; Ke Xu,, M.D., Ph.D.; Jenny Ekholm, M.S.; Serge Sevy, M.D., M.B.A.; Handan Gunduz-Bruce, M.D.; Margaret G. Woerner, Ph.D.; John M. Kane, M.D.; David Goldman, M.D.; Anil K. Malhotra, M.D.
Dysbindin Genotype and Negative Symptoms in Schizophrenia
Pamela DeRosse, M.A.; Birgit Funke, Ph.D.; Katherine E. Burdick, Ph.D.; Todd Lencz, Ph.D.; Jenny M. Ekholm, M.S.; John M. Kane, M.D.; Raju Kucherlapati, Ph.D.; Anil K. Malhotra, M.D.
BDNF Val66Met Polymorphism and GAD67 mRNA Expression in the Prefrontal Cortex of Subjects With Schizophrenia
Takanori Hashimoto, M.D., Ph.D.; David A. Lewis, M.D.
No Evidence for an Effect of COMT Val158Met Genotype on Executive Function in Patients With 22q11 Deletion Syndrome
Bronwyn Glaser, M.A.; Martin Debbane, M.A.; Christine Hinard, Ph.D.; Michael A. Morris, Ph.D.; Sophie P. Dahoun, M.D.; Stylianos E. Antonarakis, M.D.; Stephan Eliez, M.D.
Cellular Basis of Reduced Cortical Reelin Expression in Schizophrenia
Sharon L. Eastwood, D.Phil.; Paul J. Harrison, D.M. (Oxon), F.R.C.Psych.
Antisaccade Performance in Monozygotic Twins Discordant for Schizophrenia: The Maudsley Twin Study
Ulrich Ettinger, Ph.D.; Marco Picchioni, M.R.C.P., M.R.C.Psych.; Mei-Hua Hall, M.Sc.; Katja Schulze, M.Sc.; Timothea Toulopoulou, Ph.D.; Sabine Landau, Ph.D.; Trevor J. Crawford, Ph.D.; Robin M. Murray, M.D., D.Sc.
Treatment in Psychiatry
The Schizophrenia Prodrome
Tonya White, M.D.; Afshan Anjum, M.D.; S. Charles Schulz, M.D.
Letter to the Editor
Sudden Akathisia After a Ziprasidone Dose Reduction
E. TIMUCIN ORAL, M.D.; KURSAT ALTINBAS, M.D.; SIMDEN DEMIRKIRAN, M.D.
Munchausen’s Syndrome With 20-Year Follow-Up
COREY R. FEHNEL, B.S.; ERIC J. BREWER, M.D.
Neuroleptic Malignant Syndrome Related to a Switch to Perospirone and Anticholinergic Withdrawal
HISASHI TANII, M.D., Ph.D.; KOHEI FUJITA, M.D.; YUJI OKAZAKI, M.D.
Psychosis Related to Ropinirole
ELENA PEREA, M.S.; BRIAN V. ROBBINS, M.D.; BURTON HUTTO, M.D.
Trimipramine for Refractory Panic Attacks
DOMINGO CERRA, M.D.
Euphorigenic and Abusive Properties of Modafinil
STEFAN P. KRUSZEWSKI, M.D.
Osteoporosis and Schizophrenia
JOSEPH LEVINE, M.D.; ROBERT H. BELMAKER, M.D.
Dr. Cipriani and Colleagues Reply
ANDREA CIPRIANI, M.D.; HEATHER PRETTY, M.L.I.S.; KEITH HAWTON, D.SC.; JOHN R. GEDDES, M.D.
Lithium and Suicidality Revisited
BERNHARD J. CONNEMANN, M.D.
Dr. McDougle and Colleagues Reply
CHRISTOPHER J. McDOUGLE, M.D.; LAWRENCE SCAHILL, M.S.N., Ph.D.; MICHAEL G. AMAN, Ph.D.; L. EUGENE ARNOLD, M.Ed., M.D.; JAMES T. McCRACKEN, M.D.; ELAINE TIERNEY, M.D.; BENEDETTO VITIELLO, M.D.
Risperidone for the Core Symptom Domains of Autism
BABATUNDE ADETUNJI, M.D.; MAJU MATHEWS, M.D.; THOMAS OSINOWO, M.D.; ADEDAPO WILLIAMS, M.D.
Chronic Stress and Adaptation
HAROLD KUDLER, M.D.
Am J Psychiatry 2006 163: 553-553
SHARON MONTERRUBIO, B.Psych.; NADIA SOLOWIJ, Ph.D.
Drs. Brady and Sinha Reply
KATHLEEN BRADY, M.D., Ph.D.; RAJITA SINHA, Ph.D.
The CATIE Study
JEFFREY TEICH, M.D.
Am J Psychiatry 2006 163: 555-555
BIJU BASIL, M.D.; MAJU MATHEWS, M.D., M.R.C.Psych.; BABATUNDE ADETUNJI, M.D.; KUMAR BUDUR, M.D.
Dr. Lieberman and Colleagues Reply
JEFFREY A. LIEBERMAN, M.D.; T. SCOTT STROUP, M.D., M.P.H.; JOSEPH P. McEVOY, M.D.; MARVIN S. SWARTZ, M.D.; ROBERT A. ROSENHECK, M.D.; DIANA O. PERKINS, M.D., M.P.H.; RICHARD S.E. KEEFE, Ph.D.; SONIA M. DAVIS, Dr.P.H.; CLARENCE E. DAVIS, Ph.D.; JOHN HSIAO, M.D.; JOANNE SEVERE, M.S.; BARRY D. LEBOWITZ, Ph.D.; the CATIE Investigators
Book Forum
Divided Minds
GEORGE E. VAILLANT, M.D.
The American Psychiatric Publishing Textbook of Personality Disorders
JOSHUA GROSSMAN, M.D.
Brain Fiction: Self-Deception and the Riddle of Confabulation
JOHANNES PANTEL, M.D., PH.D.
Offender Profiling: An Introduction to the Sociopsychological Analysis of Violent Crime
ABILASH A. GOPAL, B.A.; HAROLD J. BURSZTAJN, M.D.
Cognitive Neuroscience of Aging: Linking Cognitive and Cerebral Aging
DAN G. BLAZER, M.D., PH.D.
Images in Psychiatry
Abraham Arden Brill, 1874–1948
Arnold D. Richards, M.D.; Paul W. Mosher, M.D.
Introspections
A Tension to Detail
SAMUEL G. SIRIS, M.D.
Correction
Correction
Books Received
Books Received
  |  
Copyright ©
American
Psychiatric
Association